Navitoclax
Regulatory
Legal Status in 2026
In active US clinical trials (Phase 2 or later); no FDA approval yet.
This compound is under active investigation in US clinical trials (Phase 2 or later) and has not yet received FDA approval. It is not legally available for prescription or compounding outside of enrolled clinical trial settings. The risk-benefit profile is not yet established for the general population.
About
About Navitoclax
Navitoclax (ABT-263) is a BCL-2/BCL-xL inhibitor originally developed as a cancer therapeutic that has demonstrated potent senolytic activity in preclinical aging models, extending lifespan and improving physical function in aged mice. Its clinical use in oncology is limited by platelet toxicity, but intermittent low-dose longevity protocols are being investigated to harness senolytic benefits while minimizing hematological side effects.
Science
Mechanism of Action
Directly inhibits BCL-2 and BCL-xL anti-apoptotic proteins that senescent cells abnormally upregulate as part of their senescence-associated anti-apoptotic program, restoring apoptosis sensitivity and enabling selective senescent cell clearance.
Dosing
Typical Protocol
Not established for longevity use; oncology doses are 150–325 mg daily. Intermittent protocols are experimental and physician-supervised only.
⚠ Protocol information is for educational purposes only. Dosing must be determined by a licensed physician based on individual health status and goals.
Evidence
Evidence Tier
Evidence primarily from animal studies, cell cultures, or small pilot human trials. Results are promising but have not yet been confirmed in large-scale human RCTs. Effects in humans may differ from animal models.
Availability
Provider availability
Navitoclax is in active clinical trials and is not available through legitimate US prescribing or compounding channels outside an enrolled trial, so Vial does not list providers for it.
This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.